ALZHEIMER

Strategy for dementia and Alzheimer´s care presented in Cuba

Published on: April 6, 2022
09:37

By: Alina Ramos Martin

Havana, Apr 6 (Prensa Latina) Experts presented the Strategy for people with dementia and Alzheimer´s care in Cuba and insisted on the importance of passing knowlegde to caregivers, in a meeting with president Miguel Diaz-Canel.

Future processes of NeuroEpo against Alzheimer’s explained in Cuba

Published on: March 28, 2022
14:38

By: Juan M. Garcia

Havana, Mar 28 (Prensa Latina) NeuroEPO, Cuba's neuroprotective drug to counteract mild and moderate Alzheimer's disease, concluded phase II/III studies and a stage IV of progressive introduction of the product is being prepared, a scientific authority noted on Monday.

Cuban drug against Alzheimer’s disease gives hope to the world

Published on: March 23, 2022
00:15

By: Juan M. Garcia

Havana, Mar 23 (Prensa Latina) The neuroprotective drug NeuralCIM, which is administered nasally, gives patients with Alzheimer's disease in Cuba and other latitudes hope from science.

President of Cuba praises registration of Alzheimer’s treatment

Published on: March 9, 2022
09:25

By: Luis Linares Petrov

Havana, Mar 9 (Prensa Latina) The President of Cuba, Miguel Díaz-Canel, today praised the approval by the national regulatory entity of the conditional health registry of the NeuroEpo molecule for mild and moderate Alzheimer's.

Cuban Alzheimer drug makes headlines in the Dominican Republic

Published on: October 22, 2021
10:33

By: Prensa Latina

Santo Domingo, Oct 22 (Prensa Latina) Dominican media outlets on Friday reported a new Cuban breakthrough, the production of the drug called Epo, an innovative product against Alzheimer's disease.

Cuba has a drug against Alzheimer’s

Published on: October 20, 2021
09:18

By: Prensa Latina

Havana, Oct 20 (Prensa Latina) The Cuban Center for State Control of Medicines, Equipment and Medical Devices is evaluating for its registration a drug called NeuroEpo, an innovative product against Alzheimer's disease.

Bumetanide shows potential as Alzheimer’s disease treatment

Published on: October 14, 2021
18:28

By: Prensa Latina

Washington, Oct 14 (Prensa Latina) A team of experts said that Bumetanide -a commonly used and potent oral diuretic pill- may provide an expected yet efficacious treatment for those at genetic risk of Alzheimer's disease, as funded by the National Institute of Aging (NIA).

Covid-19 speeds up Alzheimer’s-like symptoms

Published on: August 3, 2021
07:14

By: Prensa Latina

Geneva, Aug 3 (Prensa Latina) Scientists assured that suffering from Covid-19 speeds up Alzheirmer's-like symptoms, a specialized source reported.

Reducing junk food to avoid neurological diseases is recommended

Published on: June 29, 2021
07:46

By: Prensa Latina

London, Jun 29 (Prensa Latina) So-called junk food is considered a danger to the brain, hence experts strongly recommend to reduce or exclude it from daily diet to avert neurological diseases, the sputniknews.com website reported.

NEWS